肾脏病医生沟通工具促进保守管理的随机预试验
该随机预试验招募75岁及以上、CKD 4或5期患者74例,评估Conservative Kidney Management Jumpstart Tool的可行性与可接受性。干预组患者与肾内科医生讨论保守管理的比例显著高于对照组(60% vs 19%,P=0.001),且患者对医生沟通技巧满意度显著提升。工具可行且可接受,促进保守管理讨论。
要点
- 沟通工具使老年CKD 4-5期患者讨论保守管理的比例从19%提升至60%。
- 使用工具后患者对肾内科医生沟通技巧满意度评分从7.5升至9.0(P<0.001)。
- 对照组满意度评分无显著变化(7.8至7.9,P=0.54)。
核心结论
- 该沟通工具可行且可接受,能促进患者与肾内科医生讨论保守管理并提升沟通满意度。
研究设计与样本
- 随机预试验,招募75岁及以上CKD 4或5期患者74例,1:1随机分为干预组(肾内科医生使用沟通工具)和对照组(常规护理)。
主要发现
- 干预组60%患者报告在就诊时讨论了保守管理,对照组为19%(P=0.001)。
- 干预组患者对医生沟通技巧满意度评分从就诊前7.5±2.1升至就诊后9.0±1.7(P<0.001)。
- 对照组满意度评分从7.8±1.9变为7.9±1.8(P=0.54),无显著变化。
关键数值与推荐
- 主要结局为患者报告的保守管理讨论,采用卡方检验进行意向性分析。
- 次要结局为沟通技巧满意度变化,采用Quality of Communication Scale(评分越高代表质量越高),配对样本t检验。
临床怎么用
- 肾内科医生可使用该沟通工具,在老年CKD 4-5期患者就诊时引导讨论保守管理选项。
局限性
- 预试验样本量小(74例),年龄80±1岁,19%女性,69%白人,结果推广需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Conservative kidney management is infrequently presented to patients as a treatment option for kidney failure. Conservative Kidney Management Jumpstart Tool is a communication tool that helps nephrologists discuss patients' values and care options. The tool improved discussions about values and conservative management with patients. BACKGROUND: It is difficult for patients to make informed decisions about kidney failure unless they know all their treatment options. Conservative management is an important option infrequently presented alongside other kidney failure treatments by nephrologists. METHODS: We conducted a randomized pilot trial testing the feasibility and acceptability of a communication tool, called the Conservative Kidney Management Jumpstart Tool, in assisting nephrologists with discussing conservative management with their patients. We recruited patients aged 75 years or older with stage 4 or 5 CKD in the greater Seattle area between April 2023 and May 2025. Patients were randomized in 1:1 fashion to either their nephrologists receiving the tool to use with them at their next clinic visit (intervention) or usual care (control). Our primary outcome and feasibility measure was patient-reported discussion of conservative management during the clinic visit. Our secondary outcome and acceptability measure was change in patients' satisfaction with their nephrologist's serious illness communication skills (using the Quality of Communication Scale, with higher scores indicating higher quality) before and after the visit. We performed an intent-to-treat analysis of the primary end point using a chi-squared test. We used paired-samples t tests to assess within-patient changes in the secondary end point. RESULTS: We randomized 74 patients (age 80±1, 19% women, 69% White) to either the control ( n =37) or intervention ( n =37) group. Patients whose nephrologists received the tool were more likely to discuss conservative management during their clinic visit (60% versus 19%, P = 0.001) than patients in the control group. Patients whose nephrologists received the tool rated their nephrologist's communication skills at 7.5±2.1 before the visit and 9.0±1.7 after the visit ( P < 0.001) as compared with 7.8±1.9 and 7.9±1.8 ( P = 0.54), respectively, among patients in the control group. CONCLUSIONS: The tool was feasible and acceptable to patients, promoting patient-nephrologist discussion of conservative management and improving patients' satisfaction with their nephrologist's communication skills. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: ClinicalTrials.gov ID: NCT05753020 .
引用
- Wong SPY, Gaughran O, Prince DK, et al. A Randomized Pilot Trial of a Nephrologist Communication Tool for Discussing Conservative Management. Clin J Am Soc Nephrol. 2026. PMID: 42690921. doi:10.2215/CJN.0000001213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。